Free Newsletter
Stem cell transplant a success against Parkinson's
New research published in The Journal of Neuroscience asserts that transplanted neural stem cells can reduce the destruction of dopaminergic cells and replace cells lost to Parkinson's. A neural stem cell transplant in an animal study demonstrated that the animals continued to function normally, without the progressive loss of physical control that characterizes Parkinson's. The transplant occurred after a toxin was used to destroy neurons that are needed to make dopamine, a key neurotransmitter. The researchers said the therapy occurred at what would be the equivalent of an early stage of the disease.
"We are very cautious but to us, it's an indication that stem cells have promise for Parkinson's disease," says Dr. Cesario V. Borlongan, neuroscientist at the Medical College of Georgia and corresponding author of the study.
- read the report on the study
Related Articles:
NIH researchers study genetic variations in Parkinson's disease. Report
FDA rejects Impax Labs' Parkinson's therapy. Report
More stories about Stem Cells medical college of georgia neurotransmitter dopamine Parkinson Disease genetic variation
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
